• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Lancet Reg Health Southeast Asia . The COVID-19 laboratory response in Timor-Leste; a story of collaboration

tetano

Editor, Senior Moderator
Lancet Reg Health Southeast Asia


. 2023 Apr;11:100150.
doi: 10.1016/j.lansea.2023.100150. Epub 2023 Jan 13.
The COVID-19 laboratory response in Timor-Leste; a story of collaboration


Nevio Sarmento[SUP] 1 2 [/SUP], Endang Soares da Silva[SUP] 2 [/SUP], Ismael Barreto[SUP] 1 [/SUP], João C Ximenes[SUP] 3 [/SUP], Julia M Angelina[SUP] 3 [/SUP], Dircia M Correia[SUP] 3 [/SUP], Silvia M Babo[SUP] 3 [/SUP], Ari Jayanti P Tilman[SUP] 2 [/SUP], Antonio Salles de Sousa[SUP] 1 [/SUP], Elisabeth Hornay[SUP] 2 [/SUP], Lourenço C Ico[SUP] 1 [/SUP], Filipe de Neri Machado[SUP] 4 [/SUP], Maria Varela Niha[SUP] 4 [/SUP], Susan Ballard[SUP] 5 [/SUP], Chantel Lin[SUP] 5 [/SUP], Benjamin Howden[SUP] 5 [/SUP], Rob Baird[SUP] 6 [/SUP], Johanna Wapling[SUP] 1 [/SUP], Lucsendar Alves[SUP] 1 [/SUP], Tessa Oakley[SUP] 1 [/SUP], Ian Marr[SUP] 1 [/SUP], Anthony D K Draper[SUP] 1 7 8 [/SUP], Paul Arkell[SUP] 1 9 [/SUP], Heidi Smith-Vaughan[SUP] 1 [/SUP], Nicholas S S Fancourt[SUP] 1 [/SUP], Jennifer Yan[SUP] 1 [/SUP], Joshua R Francis[SUP] 1 [/SUP]



Affiliations

Abstract

Timor-Leste is a small nation of 1.3 million people which shares a land border with Indonesia and is 550 km from Darwin, Australia. It is one of the poorest nations in Asia. The National Health Laboratory (NHL) and its network of smaller laboratories in Timor-Leste had limited capacity to perform molecular diagnostic testing before the coronavirus disease 2019 (COVID-19) pandemic began. With the support of international development partners, the NHL rapidly expanded its molecular testing service. From March 2020 to February 2022, over 200,000 molecular tests were performed; COVID-19 testing sites were established in hospital and community health center laboratories and all 13 municipalities, and the number of scientists and technicians at the molecular diagnostic laboratory at the NHL increased from five to 28 between 2019 and 2022. Molecular diagnostic testing for COVID-19 was successfully established at the NHL and in the municipalities. The molecular diagnostic laboratory at NHL is now equipped to respond to not only large-scale COVID-19 testing but also laboratory detection of other infectious diseases, preparing Timor-Leste for future outbreaks or pandemics.

Keywords: COVID-19; Collaboration; Laboratory response; Low-resource; Pandemic; SARS-CoV-2; Timor-Leste.
 
Back
Top Bottom